Market Cap 40.42M
Revenue (ttm) 30,000.00
Net Income (ttm) -2.91M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -9,700.00%
Debt to Equity Ratio 0.00
Volume 1,570,200
Avg Vol 701,688
Day's Range N/A - N/A
Shares Out 454.67M
Stochastic %K 21%
Beta 1.00
Analysts Strong Buy
Price Target N/A

Company Profile

Vivos Inc., a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. The company develops an yttrium-90 based precision radionuclide therapy device; RadioGel, which is an injectable particle-gel for Precision Radionuclide Therapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. It is also developing a universal laboratory cooling device; hydro...

Industry: Medical Devices
Sector: Healthcare
Phone: 509 222 2222
Address:
1030 N Center Parkway, Suite N288, Kennewick, United States
Execlife
Execlife Nov. 14 at 5:42 PM
$RDGL if you're one of the people shorting this company or just actively trying to see it fail, I honestly hope you understand what you're doing. Out of all the stocks in the world, you choose to bet against the one that's literally saving lives, posting updates almost every week about the good they're doing. How do you sleep? You can't put that kind of energy out into the world and not have it come back. And when that karma comes, it's not going to be a light tap. It's the kind of heavy, life-altering reckoning that finds you, and finds your family. You're building that debt. I hope you're ready for the day it comes to collect. In the end, cancer is a bitch.
2 · Reply
Doccjc62
Doccjc62 Nov. 14 at 5:21 PM
$RDGL Global expansion of RadioGel has a good ring to it. Looking forward to the IDE approval here in the US. Imo, that will be Q1 2026.
2 · Reply
Doccjc62
Doccjc62 Nov. 14 at 5:19 PM
$RDGL https://x.com/VivosIncUSA/status/1989345771020509452?s=20
0 · Reply
Daybyday5
Daybyday5 Nov. 14 at 2:58 PM
0 · Reply
zoomnewm
zoomnewm Nov. 14 at 3:32 AM
2 · Reply
UWB67
UWB67 Nov. 13 at 2:43 PM
$RDGL The following is very likely no longer an obstacle for Vivos to resubmit the IDE application as the US government has reopened: "The government shutdown is stretching FDA resources so this process may take a bit longer than expected." - Vivos' 12 November 2025 Form 10-Q -- An announcement from Vivos on the Drugs Controller General of India (DCGI) approving Vivos to conduct international clinical trials in India for commercial applications in India is likely to be out any day now! GO VIVOS-US GO! GO VIVOS-INDIA GO! GO VIVOS-ISOPET GO!
0 · Reply
UWB67
UWB67 Nov. 12 at 2:36 PM
$RDGL The US Senate PASSED a spending bill to end the government shutdown. The US House of Representatives will try to end the shutdown TODAY (12 September 2025). Still, the FDA CONTINUES to review existing submissions despite the US government shutdown, according to the FY 2026 HHS Contingency Staffing Plan for Operations in the Absence of Enacted Annual Appropriations. Also, NO user fee is required for IDE application submissions, according to the FDA's Medical Device User Fees page. "The government shutdown is stretching FDA resources so this process may take a bit longer than expected." - Vivos' 12 November 2025 Form 10-Q The US government shutdown is not a huge concern for me. -- An announcement from Vivos on the Drugs Controller General of India (DCGI) approving Vivos to conduct international clinical trials in India for commercial applications in India should be out any day now! GO VIVOS-US GO! GO VIVOS-INDIA GO! GO VIVOS-ISOPET GO!
0 · Reply
UWB67
UWB67 Nov. 12 at 1:26 PM
$RDGL Vivos does NOT state additional data from Drugs Controller General of India (DCGI) approved clinical trials in India will be used to support Vivos' CURRENT IDE application for lymph nodes associated with thyroid cancer (Vivos' future IDE applications will focus on intended usese beyond the current application): "Company’s intent is to submit one more pre-submission document on activity containment, then resubmit the IDE." - Vivos' 12 Nov 2025 Form 10-Q -- An announcement from Vivos on the Drugs Controller General of India (DCGI) approving Vivos to conduct international clinical trials in India for commercial applications in India should be out any day now! GO VIVOS-US GO! GO VIVOS-INDIA GO! GO VIVOS-ISOPET GO!
0 · Reply
zoomnewm
zoomnewm Nov. 12 at 12:12 PM
$RDGL https://www.otcmarkets.com/filing/html?id=18910557&guid=kMb-keLsyowRkih
3 · Reply
UWB67
UWB67 Nov. 12 at 11:21 AM
$RDGL Vivos' 12 November 2025 Form 10-Q is out! An announcement from Vivos on the Drugs Controller General of India (DCGI) approving Vivos to conduct international clinical trials in India for commercial applications in India should be out any day now! -- GO VIVOS-US GO! GO VIVOS-INDIA GO! GO VIVOS-ISOPET GO!
0 · Reply
Latest News on RDGL
No data available.
Execlife
Execlife Nov. 14 at 5:42 PM
$RDGL if you're one of the people shorting this company or just actively trying to see it fail, I honestly hope you understand what you're doing. Out of all the stocks in the world, you choose to bet against the one that's literally saving lives, posting updates almost every week about the good they're doing. How do you sleep? You can't put that kind of energy out into the world and not have it come back. And when that karma comes, it's not going to be a light tap. It's the kind of heavy, life-altering reckoning that finds you, and finds your family. You're building that debt. I hope you're ready for the day it comes to collect. In the end, cancer is a bitch.
2 · Reply
Doccjc62
Doccjc62 Nov. 14 at 5:21 PM
$RDGL Global expansion of RadioGel has a good ring to it. Looking forward to the IDE approval here in the US. Imo, that will be Q1 2026.
2 · Reply
Doccjc62
Doccjc62 Nov. 14 at 5:19 PM
$RDGL https://x.com/VivosIncUSA/status/1989345771020509452?s=20
0 · Reply
Daybyday5
Daybyday5 Nov. 14 at 2:58 PM
0 · Reply
zoomnewm
zoomnewm Nov. 14 at 3:32 AM
2 · Reply
UWB67
UWB67 Nov. 13 at 2:43 PM
$RDGL The following is very likely no longer an obstacle for Vivos to resubmit the IDE application as the US government has reopened: "The government shutdown is stretching FDA resources so this process may take a bit longer than expected." - Vivos' 12 November 2025 Form 10-Q -- An announcement from Vivos on the Drugs Controller General of India (DCGI) approving Vivos to conduct international clinical trials in India for commercial applications in India is likely to be out any day now! GO VIVOS-US GO! GO VIVOS-INDIA GO! GO VIVOS-ISOPET GO!
0 · Reply
UWB67
UWB67 Nov. 12 at 2:36 PM
$RDGL The US Senate PASSED a spending bill to end the government shutdown. The US House of Representatives will try to end the shutdown TODAY (12 September 2025). Still, the FDA CONTINUES to review existing submissions despite the US government shutdown, according to the FY 2026 HHS Contingency Staffing Plan for Operations in the Absence of Enacted Annual Appropriations. Also, NO user fee is required for IDE application submissions, according to the FDA's Medical Device User Fees page. "The government shutdown is stretching FDA resources so this process may take a bit longer than expected." - Vivos' 12 November 2025 Form 10-Q The US government shutdown is not a huge concern for me. -- An announcement from Vivos on the Drugs Controller General of India (DCGI) approving Vivos to conduct international clinical trials in India for commercial applications in India should be out any day now! GO VIVOS-US GO! GO VIVOS-INDIA GO! GO VIVOS-ISOPET GO!
0 · Reply
UWB67
UWB67 Nov. 12 at 1:26 PM
$RDGL Vivos does NOT state additional data from Drugs Controller General of India (DCGI) approved clinical trials in India will be used to support Vivos' CURRENT IDE application for lymph nodes associated with thyroid cancer (Vivos' future IDE applications will focus on intended usese beyond the current application): "Company’s intent is to submit one more pre-submission document on activity containment, then resubmit the IDE." - Vivos' 12 Nov 2025 Form 10-Q -- An announcement from Vivos on the Drugs Controller General of India (DCGI) approving Vivos to conduct international clinical trials in India for commercial applications in India should be out any day now! GO VIVOS-US GO! GO VIVOS-INDIA GO! GO VIVOS-ISOPET GO!
0 · Reply
zoomnewm
zoomnewm Nov. 12 at 12:12 PM
$RDGL https://www.otcmarkets.com/filing/html?id=18910557&guid=kMb-keLsyowRkih
3 · Reply
UWB67
UWB67 Nov. 12 at 11:21 AM
$RDGL Vivos' 12 November 2025 Form 10-Q is out! An announcement from Vivos on the Drugs Controller General of India (DCGI) approving Vivos to conduct international clinical trials in India for commercial applications in India should be out any day now! -- GO VIVOS-US GO! GO VIVOS-INDIA GO! GO VIVOS-ISOPET GO!
0 · Reply
Chapdaddy14
Chapdaddy14 Nov. 11 at 3:08 PM
$RDGL love that this company is getting some exposure 🚀🚀
2 · Reply
UWB67
UWB67 Nov. 11 at 2:42 PM
$RDGL Let's see what a press release on Drugs Controller General of India (DCGI) approving Vivos to conduct international clinical trials in India for commercial applications in India will do to the share price with this current momentum! Any day now. GO VIVOS-US GO! GO VIVOS-INDIA GO! GO VIVOS-ISOPET GO!
0 · Reply
dandanthefireman
dandanthefireman Nov. 11 at 2:39 PM
0 · Reply
Doccjc62
Doccjc62 Nov. 10 at 5:38 PM
$RDGL Nice to see the share price almost touch .10 this morning. A lot happening with the IDE, and great to have the consultants guiding us through the process. Let’s not forget IsoPet and PrecisionGel — both key pieces here. Are we expecting the 10Q this week? That could explain the recent bump. In my opinion, it won’t take much to really move the share price from here.
0 · Reply
Cheltenham58
Cheltenham58 Nov. 10 at 4:18 PM
0 · Reply
UWB67
UWB67 Nov. 10 at 3:37 PM
0 · Reply
Dark_Angle
Dark_Angle Nov. 9 at 2:39 AM
$SERV $RDGL $SOFI hi…. I’m looking for a bro that has gone missing… just wanted to say… I do miss you man!! Come back to the group. You are missed! You are crazy just like me!!! You wicked man!!! 😂😂😂😂
1 · Reply
Techallure
Techallure Nov. 8 at 7:39 PM
0 · Reply
Phil1981
Phil1981 Nov. 8 at 4:31 AM
$RDGL We going up baby, love the news!
1 · Reply
Techallure
Techallure Nov. 7 at 8:21 PM
$OTLC Who hits .33 first? $OTLC or $RDGL ? Will come down to a photo finish …and both break out from the pack
1 · Reply
Techallure
Techallure Nov. 7 at 8:16 PM
$RDGL eyes begin to widen … as the weekend brings emotions of should have averaged down
0 · Reply
MnWalleye1
MnWalleye1 Nov. 7 at 8:07 PM
0 · Reply